Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Neoplasms 3Head and Neck Neoplasms 2Endometrial Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Ovarian Carcinosarcoma 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Laryngeal Diseases 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 9Specimen Handling 8Cisplatin 5Cetuximab 5Platinum 41,2-diaminocyclohexaneplatinum II citrate 4cemiplimab 3Radiotherapy 3Immunoglobulin G 3Disulfides 3Biopsy 3(225)Ac-DOTA-c(RGDyK) 3pembrolizumab 2Radiotherapy, Intensity-Modulated 2Radiation 2Nivolumab 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1temsirolimus 1niraparib 1ipatasertib 1durvalumab 1dostarlimab 1cabozantinib 1atezolizumab 1Valproic Acid 1Ultrasonography 1Transurethral Resection of Bladder 1Tramadol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × dostarlimab × 30 days × Clear all
NCT05784012 2026-06-04

RADIAN

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Phase 1/2 Active not recruiting
34 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡